ReNeuron Group (FRA:RQE1) Accumulated Depreciation : €0.00 Mil (As of Sep. 2023)

View and export this data going back to 2007. Start your Free Trial

What is ReNeuron Group Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

ReNeuron Group's quarterly accumulated depreciation increased from Sep. 2022 (€0.00 Mil) to Mar. 2023 (€-2.23 Mil) but then stayed the same from Mar. 2023 (€-2.23 Mil) to Sep. 2023 (€0.00 Mil).

ReNeuron Group's annual accumulated depreciation increased from Mar. 2021 (€-1.52 Mil) to Mar. 2022 (€-2.17 Mil) and increased from Mar. 2022 (€-2.17 Mil) to Mar. 2023 (€-2.23 Mil).

ReNeuron Group Accumulated Depreciation Historical Data

The historical data trend for ReNeuron Group's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ReNeuron Group Accumulated Depreciation Chart

ReNeuron Group Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Accumulated Depreciation

Get a 7-Day Free Trial

-0.95

-1.17

-1.52

-2.17

-2.23

ReNeuron Group Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Accumulated Depreciation	Get a 7-Day Free Trial															-	-2.17	-	-2.23	-

ReNeuron Group Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

ReNeuron Group Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of ReNeuron Group's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

ReNeuron Group (FRA:RQE1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ReNeuron Group PLC (FRA:RQE1) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

RNUGF:USA RENE.GB:UK RENE:UK

Address

Pencoed Business Park, Pencoed, Bridgend, GBR, CF35 5HY

Website

https://www.reneuron.com

ReNeuron Group PLC is engaged in the field of biotechnology. Its core activities include the research and clinical development of cell-based therapeutics. The company product pipeline includes the human retinal progenitor cell line (hRPC) and CTX neural cell line. It derives revenue from UK and U.S. The company is mainly focusing on the treatment of stroke disability, inherited retinal diseases, and cancer.

ReNeuron Group (FRA:RQE1) Headlines

No Headlines